Surya K. De* Pages 1 - 4 ( 4 )
This patent describes the novel pyrroloppyrimidine compounds as LRRK2 kinase inhibitors. The patent includes the synthesis of compounds, compositions containing them and their use in the treatment of or prevention of diseases associated with LRRK2 kinase activity, such as Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS).
Pyrrolopyrimidines, LRRK2 kinase, Parkinson’s disease, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Mutation of LRRK2.